Charcot Marie Tooth Disease Clinical Trial
Official title:
Mexiletine for Muscle Cramps in Charcot Marie Tooth Disease
Charcot Marie Tooth Disease is a family of inherited peripheral neuropathies, with over 70 causative genes identified to date.1-4 Muscle cramps are frequent in CMT, affecting up to 85% of patients with some subtypes of CMT. These cramps impact quality of life and have been identified as an important therapeutic target for clinical trials in CMT.1-4 There is no FDA approved treatment for muscle cramps.5 Mexiletine is a sodium channel blocker approved for treatment of arrhythmias. As a sodium channel blocker, mexiletine offers the promise of effective therapy for muscle cramps.
This study will provide data on the short term efficacy of oral mexiletine in helping to prevent muscle cramps in adults with CMT. The study will also assess the short-term safety and tolerability of low dose mexiletine in adults with CMT. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00541164 -
Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease
|
Phase 1/Phase 2 | |
| Recruiting |
NCT01918826 -
Evaluation of the Analgesic Efficiency of the Transcutaneous Neurostimulation in the Charcot Syndrome Marie Tooth on the Pains of Lower Limbs
|
N/A | |
| Completed |
NCT01455623 -
Development and Validation of a Disability Severity Index for CMT
|
N/A | |
| Completed |
NCT02194010 -
Disability Severity Scale (DSI) and Hereditary Motor and Sensory Neuropathy Overall Disability Scale (HMSN-R-ODS)
|
||
| Recruiting |
NCT01203085 -
Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT
|
||
| Recruiting |
NCT01193075 -
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others
|